
Isaac Shomer
Examiner (ID: 12146, Phone: (571)270-7671 , Office: P/1612 )
| Most Active Art Unit | 1612 |
| Art Unit(s) | 1612 |
| Total Applications | 1343 |
| Issued Applications | 756 |
| Pending Applications | 157 |
| Abandoned Applications | 491 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16025901
[patent_doc_number] => 10675350
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-09
[patent_title] => Nanoparticles of indirubin, derivatives thereof and methods of making and using same
[patent_app_type] => utility
[patent_app_number] => 16/040640
[patent_app_country] => US
[patent_app_date] => 2018-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8272
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16040640
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/040640 | Nanoparticles of indirubin, derivatives thereof and methods of making and using same | Jul 19, 2018 | Issued |
Array
(
[id] => 15963589
[patent_doc_number] => 20200165546
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-28
[patent_title] => ENCAPSULATION METHOD
[patent_app_type] => utility
[patent_app_number] => 16/632912
[patent_app_country] => US
[patent_app_date] => 2018-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2462
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16632912
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/632912 | Encapsulation method | Jul 9, 2018 | Issued |
Array
(
[id] => 15863145
[patent_doc_number] => 20200138976
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => MINERAL COATED MICROPARTICLES FOR GENE DELIVERY IN CHRONIC WOUND THERAPY
[patent_app_type] => utility
[patent_app_number] => 16/626971
[patent_app_country] => US
[patent_app_date] => 2018-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7458
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16626971
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/626971 | Mineral coated microparticles for gene delivery in chronic wound therapy | Jul 4, 2018 | Issued |
Array
(
[id] => 18127982
[patent_doc_number] => 11554178
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-17
[patent_title] => Compositions and methods of modulating macrophage activity
[patent_app_type] => utility
[patent_app_number] => 16/625099
[patent_app_country] => US
[patent_app_date] => 2018-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 47
[patent_no_of_words] => 55725
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16625099
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/625099 | Compositions and methods of modulating macrophage activity | Jun 28, 2018 | Issued |
Array
(
[id] => 13490061
[patent_doc_number] => 20180296573
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-18
[patent_title] => DRY POWDER FORMULATION COMPRISING A CORTICOSTEROID AND A BETA-ADRENERGIC FOR ADMINISTRATION BY INHALATION
[patent_app_type] => utility
[patent_app_number] => 16/015666
[patent_app_country] => US
[patent_app_date] => 2018-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6100
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 176
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16015666
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/015666 | Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation | Jun 21, 2018 | Issued |
Array
(
[id] => 13729527
[patent_doc_number] => 20180369231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-27
[patent_title] => PARTICLE AND PHARMACEUTICAL COMPOSITION COMPRISING AN INSOLUBLE CAMPTOTHECIN COMPOUND WITH DOUBLE CORE-SHELL STRUCTURE AND METHOD FOR MANUFACTURING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/015470
[patent_app_country] => US
[patent_app_date] => 2018-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11010
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16015470
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/015470 | Particle and pharmaceutical composition comprising an insoluble camptothecin compound with double core-shell structure and method for manufacturing the same | Jun 21, 2018 | Issued |
Array
(
[id] => 13616959
[patent_doc_number] => 20180360031
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-20
[patent_title] => MICROENCAPSULATION
[patent_app_type] => utility
[patent_app_number] => 16/009686
[patent_app_country] => US
[patent_app_date] => 2018-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7979
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16009686
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/009686 | MICROENCAPSULATION | Jun 14, 2018 | Abandoned |
Array
(
[id] => 17148326
[patent_doc_number] => 11141377
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-12
[patent_title] => Nanostructured lipid carriers and stable emulsions and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/622908
[patent_app_country] => US
[patent_app_date] => 2018-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 82
[patent_figures_cnt] => 57
[patent_no_of_words] => 54534
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16622908
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/622908 | Nanostructured lipid carriers and stable emulsions and uses thereof | Jun 14, 2018 | Issued |
Array
(
[id] => 13533349
[patent_doc_number] => 20180318217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-08
[patent_title] => Liposomal Curcumin for Treatment of Diseases
[patent_app_type] => utility
[patent_app_number] => 16/007283
[patent_app_country] => US
[patent_app_date] => 2018-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16757
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16007283
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/007283 | Liposomal Curcumin for Treatment of Diseases | Jun 12, 2018 | Abandoned |
Array
(
[id] => 16267179
[patent_doc_number] => 20200268666
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => POLYNUCLEOTIDES ENCODING COAGULATION FACTOR VIII
[patent_app_type] => utility
[patent_app_number] => 16/621514
[patent_app_country] => US
[patent_app_date] => 2018-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 92317
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16621514
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/621514 | POLYNUCLEOTIDES ENCODING COAGULATION FACTOR VIII | Jun 12, 2018 | Abandoned |
Array
(
[id] => 17633795
[patent_doc_number] => 11344499
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-31
[patent_title] => Nanoparticles as delivery vehicles of active ingredients and methods for the production thereof
[patent_app_type] => utility
[patent_app_number] => 16/622402
[patent_app_country] => US
[patent_app_date] => 2018-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 13
[patent_no_of_words] => 8585
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16622402
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/622402 | Nanoparticles as delivery vehicles of active ingredients and methods for the production thereof | Jun 12, 2018 | Issued |
Array
(
[id] => 15960225
[patent_doc_number] => 20200163864
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-28
[patent_title] => COMBINATION OF POLYION COMPLEX PARTICLE AND NON-POLYMERIC ACID OR BASE HAVING TWO OR MORE DISSOCIATION CONSTANTS
[patent_app_type] => utility
[patent_app_number] => 16/619899
[patent_app_country] => US
[patent_app_date] => 2018-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21682
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16619899
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/619899 | COMBINATION OF POLYION COMPLEX PARTICLE AND NON-POLYMERIC ACID OR BASE HAVING TWO OR MORE DISSOCIATION CONSTANTS | Jun 7, 2018 | Abandoned |
Array
(
[id] => 13941349
[patent_doc_number] => 10206417
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2019-02-19
[patent_title] => Guava seed (
[patent_app_type] => utility
[patent_app_number] => 16/003042
[patent_app_country] => US
[patent_app_date] => 2018-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 2368
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16003042
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/003042 | Guava seed ( | Jun 6, 2018 | Issued |
Array
(
[id] => 15663979
[patent_doc_number] => 10596197
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-24
[patent_title] => Red blood cell membrane-derived microparticles and their use for the treatment of lung disease
[patent_app_type] => utility
[patent_app_number] => 15/995513
[patent_app_country] => US
[patent_app_date] => 2018-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 21
[patent_no_of_words] => 13844
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15995513
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/995513 | Red blood cell membrane-derived microparticles and their use for the treatment of lung disease | May 31, 2018 | Issued |
Array
(
[id] => 20479280
[patent_doc_number] => 12527742
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-20
[patent_title] => Methods for manufacturing a liposome encapsulated RNA
[patent_app_type] => utility
[patent_app_number] => 16/617016
[patent_app_country] => US
[patent_app_date] => 2018-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 17568
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 301
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16617016
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/617016 | Methods for manufacturing a liposome encapsulated RNA | May 29, 2018 | Issued |
Array
(
[id] => 13492791
[patent_doc_number] => 20180297938
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-18
[patent_title] => COMPOUNDS FOR TARGETING DRUG DELIVERY AND ENHANCING siRNA ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 15/985614
[patent_app_country] => US
[patent_app_date] => 2018-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15739
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15985614
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/985614 | Compounds for targeting drug delivery and enhancing siRNA activity | May 20, 2018 | Issued |
Array
(
[id] => 13548733
[patent_doc_number] => 20180325914
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-15
[patent_title] => INCREASING STORAGE OF VITAMIN A, VITAMIN D AND/OR LIPIDS
[patent_app_type] => utility
[patent_app_number] => 15/984146
[patent_app_country] => US
[patent_app_date] => 2018-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32512
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15984146
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/984146 | INCREASING STORAGE OF VITAMIN A, VITAMIN D AND/OR LIPIDS | May 17, 2018 | Abandoned |
Array
(
[id] => 13440713
[patent_doc_number] => 20180271899
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-27
[patent_title] => OXYGEN-ENABLED COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 15/983602
[patent_app_country] => US
[patent_app_date] => 2018-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5512
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15983602
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/983602 | Oxygen-enabled composition | May 17, 2018 | Issued |
Array
(
[id] => 19440067
[patent_doc_number] => 12090294
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-17
[patent_title] => Targeted drug delivery methods using a microneedle
[patent_app_type] => utility
[patent_app_number] => 16/609583
[patent_app_country] => US
[patent_app_date] => 2018-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 72
[patent_no_of_words] => 19716
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16609583
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/609583 | Targeted drug delivery methods using a microneedle | May 1, 2018 | Issued |
Array
(
[id] => 14774867
[patent_doc_number] => 20190262331
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2019-08-29
[patent_title] => Stabilizing Camptothecin Pharmaceutical Compositions
[patent_app_type] => utility
[patent_app_number] => 15/967638
[patent_app_country] => US
[patent_app_date] => 2018-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34513
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15967638
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/967638 | Stabilizing Camptothecin Pharmaceutical Compositions | Apr 30, 2018 | Abandoned |